$4.29−$0.3900 (−8.33%) on the dayAs of the close; data may be delayed.
FMC price, last 12 months
$18.07$4.29
Daily closes over the last 260 trading sessions: −69.3%. Highest close $18.07 on , lowest $4.29 on . Market data may be delayed.
Key stats
Previous close
$4.68
Open
$4.58
Day range
$4.22 – $4.65
52-week range
$3.89 – $18.29
Volume
6.4M
Avg volume (20 days)
7.7M
Market cap
$810.5M
Performance
1W−24.0%
1M−21.1%
3M−64.9%
6M−69.8%
YTD−71.5%
1Y−68.8%
vs S&P 500, 1Y−73.6 pts
Technicals and fundamentals
About FMC Corporation
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Chart FMC with indicators, scan for setups and get alerts
This page is open to everyone. A free ScanPro account adds the interactive parts, along with watchlists, paper trading with simulated money and the Academy's quizzes.
A full FMC chart with indicator overlays, pattern markers and daily, weekly or intraday bars.
Scans of a whole index or list with 72 named conditions, 26 chart setups or a formula of your own.
Alerts and notifications when one fires on a stock you watch, on delayed market data.
Daily range (ATR)13.5%average true range, % of price
52w low $3.8952w high $18.29
Where price sits today against its own history. A description, not a forecast.
Valuation
P/E (trailing)—
P/E (forward)4.6
PEG1.55
Price / sales0.24
Price / book−34.32
EV / EBITDA—
Company figures as of Nov 19, 2026.
Analysts
ConsensusHold2.9 on 1 (strong buy) to 5 (strong sell)
Analysts14
Average target$7.55+90.7% from today
Price targets are opinions and tend to lean optimistic.
Earnings
Next results, expectedaround Feb 3, 2027 (in 75 days)A year after its Feb 4, 2026 results release; the last came Oct 29, 2026. An estimate from its SEC filings, not a date the company announced.
Average return in each calendar month, Oct 31, 2021 to Oct 31, 2026. 6 years is 6 observations a month: too few to call a pattern, so read it as history, not a calendar to trade.
Year by year
Year
J
F
M
A
M
J
J
A
S
O
N
D
Year
2026
+14
−7
+17
−11
−11
−16
−7
+8
−23
−30
−55%
2025
+15
−34
+14
−1
−3
+3
−6
+0
−14
−55
−6
−3
−71%
2024
−11
+0
+13
−7
+3
−6
+1
+11
+2
−1
−9
−18
−23%
2023
+7
−3
−5
+1
−16
+0
−8
−10
−22
−21
+1
+18
−49%
2022
+0
+6
+12
+1
−8
−13
+4
−3
−2
+12
+10
−4
+14%
2021
−1
+10
+10
+20%
Each year's monthly returns in %, the observations behind the averages. The last column compounds the year's months; a year the history only partly covers is faded.
Financials
As reported in the company's SEC filings. Latest: Q3 FY2026, ended Sep 30, 2026.
Free shows the latest quarter, the latest year and the last 12 months. Plus shows every period and the growth figures.See Plus
Figures are as each 10-Q and 10-K reported them, in the company's own fiscal calendar, not restated later. A company that changes how it reports a line can make one period look out of step with the rest. Growth compares the same period a year earlier and is left blank when the year before was a loss. Banks and insurers report no gross profit, so rows they don't file are left out. Every filing on SEC EDGAR
FMC faces a securities fraud investigation by a major law firm, issued significantly downward-revised guidance well below consensus estimates, and experienced a severe 30.53% stock price drop. The company disclosed substantial negative impacts from pricing actions and business model changes, indicating serious operational and financial challenges.
FMC faces a securities fraud investigation following a dramatic 30.53% stock price decline due to significantly missed revenue and EBITDA guidance. The company disclosed substantial negative impacts from pricing actions and business model changes, indicating operational challenges and potential misrepresentation of prior expectations to investors.
FMC reported significant losses, 80.5% revenue decline, missed earnings estimates, slashed full-year guidance by 28%, and projects negative free cash flow. The company faces softer demand and substantial commercial adjustments. Stock has lost 68.7% over the past year and carries a Zacks Rank #5 (Strong Sell) rating.
Massive earnings miss of $4.41 loss vs. $0.08 consensus estimate (-5,612.50% surprise), 67.8% year-to-date stock decline, Zacks Rank #5 (Strong Sell) rating, unfavorable estimate revisions, and significant revenue decline from $961.3M to $105.9M year-over-year.
FMC faces a securities fraud investigation following a dramatic 30.53% stock price decline due to significantly reduced financial guidance. The company reported expected negative EBITDA and substantial revenue shortfalls, indicating serious operational and financial challenges.
FMC issued a dramatic guidance cut with Q3 revenue expected to fall over 90% from analyst expectations, adjusted EBITDA projected to be deeply negative ($510-565 million), and the stock crashed 32.4%. The company faces weak demand, intense generic competition, and is forced to slash prices significantly, indicating severe operational and financial distress.
Tone is the news provider's automated reading of each article for this stock. It describes the article, not what the price will do.
Figures describe the past, not what the price will do next. Educational tools, not investment advice.